In Medical Devices, Hurry Up and Wait
Executive SummaryMedical device and biotech executives can debate which industry segment is getting a colder shoulder from venture capitalists these days, but it's clear that device start-ups are finding it no easier to attract traditional sources of financing than their counterparts in biotech.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.